학술논문

Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants
Document Type
Journal
Source
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; JAN 2018, 62 1, pe00596-17 13p.
Subject
Language
English
ISSN
10986596